These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36739649)

  • 1. A favorable alliance between repetitive use of levosimendan and advanced heart failure: Polish two-centered inpatient perspective in need of validation.
    Książczyk M; Gruchała M; Stopczyńska I; Lelonek M
    Kardiol Pol; 2023; 81(3):287-289. PubMed ID: 36739649
    [No Abstract]   [Full Text] [Related]  

  • 2. Levosimendan in patients with decompensated heart failure.
    Rosa EM; Osório AP; Scopel L
    Arq Bras Cardiol; 2008 Aug; 91(2):119. PubMed ID: 18709265
    [No Abstract]   [Full Text] [Related]  

  • 3. Levosimendan as a bridge to heart transplant: a real alternative.
    Goirigolzarri-Artaza J; Restrepo-Córdoba MA
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):302-303. PubMed ID: 38104926
    [No Abstract]   [Full Text] [Related]  

  • 4. Can we believe in levosimendan?
    Follath F
    Arq Bras Cardiol; 2008 Mar; 90(3):146-7. PubMed ID: 18392391
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of outpatient administration of levosimendan in reducing hospital readmission in patients with heart failure.
    Acosta-Armas P; Medina-Gil JM; Martínez-Quintana E
    Med Clin (Barc); 2023 Nov; 161(9):403-404. PubMed ID: 37598053
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of levosimendan in patients with cardiac amyloidosis.
    Aimo A; Rapezzi C; Arzilli C; Vergaro G; Emdin M
    Eur J Intern Med; 2020 Oct; 80():114-116. PubMed ID: 32631802
    [No Abstract]   [Full Text] [Related]  

  • 7. Levosimendan use in several scenarios of acute heart failure.
    Tavares M; Andrade AC; Mebazaa A
    Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive ambulatory levosimendan as a bridge to heart transplantation.
    de Juan Bagudá J; de Frutos F; López-Vilella R; Couto Mallón D; Guzman-Bofarull J; Blazquez-Bermejo Z; Cobo-Belaustegui M; Mitroi C; Pastor-Pérez FJ; Moliner-Abós C; Rangel-Sousa D; Díaz-Molina B; Tobar-Ruiz J; Salterain Gonzalez N; García-Pinilla JM; García-Cosío Carmena MD; Crespo-Leiro MG; Dobarro D; Almenar L; Delgado-Jiménez JF; Paredes-Galán E; González-Vílchez F; González-Costello J
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):290-301. PubMed ID: 37516313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BELIEF: believe it or not.
    Beck-da-Silva L; Fuchs FD
    Arq Bras Cardiol; 2008 Aug; 91(2):119-21. PubMed ID: 18709264
    [No Abstract]   [Full Text] [Related]  

  • 10. Levosimendan in the treatment of patients with acute cardiac conditions: an expert opinion of the Association of Intensive Cardiac Care of the Polish Cardiac Society.
    Tycińska A; Gierlotka M; Bugajski J; Deja M; Depukat R; Gruchała M; Grześk G; Kasprzak JD; Kubica J; Kucewicz-Czech E; Leszek P; Płonka J; Sobkowicz B; Straburzyńska-Migaj E; Wilk K; Zawiślak B; Zymliński R; Stępińska J
    Kardiol Pol; 2020 Aug; 78(7-8):825-834. PubMed ID: 32788567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Levosimendan Infusions in the Management of Advanced Heart Failure: Review of the Evidence and Meta-analysis of the Effect on Mortality.
    Silvetti S; Pollesello P; Belletti A
    J Cardiovasc Pharmacol; 2024 Feb; 83(2):144-157. PubMed ID: 37991393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure update.
    Gomes UC; Cleland JG
    Eur J Heart Fail; 1999 Aug; 1(3):301-2. PubMed ID: 10935680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y
    Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricuspid valve replacement and levosimendan.
    Cicekcioglu F; Parlar AI; Altinay L; Yay K; Katircioglu SF
    Gen Thorac Cardiovasc Surg; 2008 Nov; 56(11):559-62. PubMed ID: 19002757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of levosimendan on B-type natriuretic peptide levels in patients with advanced heart failure: a meta-analysis].
    Xu ZD; He WX; Zhao YF; Xia SX; He B; Yang T; Cao DX; Peng SL; Li J; Cao MH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2027-9. PubMed ID: 19861257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan.
    Grześk G; Wołowiec Ł; Rogowicz D; Gilewski W; Kowalkowska M; Banach J; Hertmanowski W; Dobosiewicz M
    Biomed Pharmacother; 2022 Sep; 153():113391. PubMed ID: 36076524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan in end-stage heart failure.
    Yeo PSD
    JACC Heart Fail; 2013 Aug; 1(4):365. PubMed ID: 24621941
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
    Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan: a novel agent in heart failure.
    Koumallos N; Antoniades C; Tousoulis D; Shirodaria C; Stefanadis C
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):185-91. PubMed ID: 18221085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan.
    Kamath SR; Jaykumar I; Matha S
    Indian Pediatr; 2009 Jul; 46(7):593-6. PubMed ID: 19638658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.